News Headline Summary
Alexion (ALXN) says new data shows clinical benefits over 10 years of Soliris
- Says data shows Soliris significantly cuts Thromboembolism risk.
- Co. shares spike 0.45% higher in immediate reaction to the news from USD 93.13 to USD 93.58.
15:32, 10 Dec 2012 -
Subscribe Now to RANsquawk
Click here for a 1 week free trial
RANsquawk provides audio news and commentary for over 15,000
professional traders and brokers worldwide. Services include:
Real-time audio coverage from 0630 to 2130 London time
Teams of analysts covering equities, fixed income, FX and energy markets
Real-time scrolling news service
Daily and weekly pre-market research and calendars
Intra-day market update videos
Daily technical analysis